Bryan Garnier - Alchemia Ltd. (ACL) ... ALCON: Post-game debrief : moving to Neutral | NEUTRAL vs. TOP PICKS | CHF57

Report

Bryan Garnier

Hugo Solvet

ALCON: Post-game debrief : moving to Neutral | NEUTRAL vs. TOP PICKS | CHF57

ALCON - NEUTRAL vs. BUY - TOP PICKS | CHF57
Post-game debrief : moving to Neutral

After having played the spin-off, we move to Neutral
Reiterate Fair Value of CHF57
Alconâ€™s investment case in a nutshell

10/04/2019 3 EN

Underlyings

Alchemia Ltd.

Alchemia is organised into one business unit, being the development and commercialisation of the HyACT platform.

See profile

AU000000ACL6 Australia

Halcon Fondo de Inversion

See profile

CL0000000373 Santiago Stock Exchange Chile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Hugo Solvet

Other Reports on these Companies

SmartInsider

Australian Clinical Labs Limited: 1 director

A director at Australian Clinical Labs Limited maiden bought 20,000 shares at 2.358AUD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing r...

Free Trial

March 5, 2024 March 5, 2024 1 EN

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

Fundamental Research

Feasibility Study Results in December to be a Catalyst for this Junior

EUR 18.77

November 25, 2019 November 25, 2019 14 EN

Waga Energy: another commissioning in France

Waga Energy yesterday announced the commissioning of a Wagabox in Chatuzange (France) on a site operated by Veolia, one of the largest European players in the waste management and utility industry. The site has been equipped with a Wagabox able to produce up to 25GWh/year of biomethane, directly in

21h / 17m 21h / 17m 1 EN

Cedric Rossi ... (+5)

Cedric Rossi
Clement Genelot
Loic Morvan
Paul Rouviere
Philippine Adam

On the shelves now: Consumer Weekly #25

In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we comment on resilient US activity from the perspective of a healthy Logistics Mana

April 22, 2024 April 22, 2024 1 EN

Loic Morvan ... (+2)

Loic Morvan
Paul Rouviere

L'Oréal reports encouraging Q1 2024 sales figures

L'Oréal's Q1 sales were above market expectations. Excluding a technical one-off positive impact, sales grew 8.1% lfl over the quarter (consensus: +6.4%) thanks to strong performances in the mass market and Derma Beauty divisions. L'Oréal continued to outperform a still dynamic beauty market (+6%).

April 19, 2024 April 19, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

ALCON: Post-game debrief : moving to Neutral | NEUTRAL vs. TOP PICKS | CHF57

Australian Clinical Labs Limited: 1 director

Monthly LMI Update Independent Investment Research

Feasibility Study Results in December to be a Catalyst for this Junior

Waga Energy: another commissioning in France

On the shelves now: Consumer Weekly #25

L'Oréal reports encouraging Q1 2024 sales figures

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe